Literature DB >> 11486032

The E2A-HLF oncoprotein activates Groucho-related genes and suppresses Runx1.

J Dang1, T Inukai, H Kurosawa, K Goi, T Inaba, N T Lenny, J R Downing, S Stifani, A T Look.   

Abstract

The E2A-HLF fusion gene, formed by the t(17;19)(q22;p13) chromosomal translocation in leukemic pro-B cells, encodes a chimeric transcription factor consisting of the transactivation domain of E2A linked to the bZIP DNA-binding and protein dimerization domain of hepatic leukemia factor (HLF). This oncoprotein blocks apoptosis induced by growth factor deprivation or irradiation, but the mechanism for this effect remains unclear. We therefore performed representational difference analysis (RDA) to identify downstream genetic targets of E2A-HLF, using a murine FL5.12 pro-B cell line that had been stably transfected with E2A-HLF cDNA under the control of a zinc-regulated metallothionein promoter. Two RDA clones, designated RDA1 and RDA3, were differentially upregulated in E2A-HLF-positive cells after zinc induction. The corresponding cDNAs encoded two WD40 repeat-containing proteins, Grg2 and Grg6. Both are related to the Drosophila protein Groucho, a transcriptional corepressor that lacks DNA-binding activity on its own but can act in concert with other proteins to regulate embryologic development of the fly. Expression of both Grg2 and Grg6 was upregulated 10- to 50-fold by E2A-HLF. Immunoblot analysis detected increased amounts of two additional Groucho-related proteins, Grg1 and Grg4, in cells expressing E2A-HLF. A mutant E2A-HLF protein with a disabled DNA-binding region also mediated pro-B cell survival and activated Groucho-related genes. Among the transcription factors known to interact with Groucho-related protein, only RUNX1 was appreciably downregulated by E2A-HLF. Our results identify a highly conserved family of transcriptional corepressors that are activated by E2A-HLF, and they suggest that downregulation of RUNX1 may contribute to E2A-HLF-mediated leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11486032      PMCID: PMC87312          DOI: 10.1128/MCB.21.17.5935-5945.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions.

Authors:  M C Ghozi; Y Bernstein; V Negreanu; D Levanon; Y Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

2.  Affinity for the nuclear compartment and expression during cell differentiation implicate phosphorylated Groucho/TLE1 forms of higher molecular mass in nuclear functions.

Authors:  J Husain; R Lo; D Grbavec; S Stifani
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

3.  Identifying differences in mRNA expression by representational difference analysis of cDNA.

Authors:  M Hubank; D G Schatz
Journal:  Nucleic Acids Res       Date:  1994-12-25       Impact factor: 16.971

4.  Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor.

Authors:  T Inaba; T Inukai; T Yoshihara; H Seyschab; R A Ashmun; C E Canman; S J Laken; M B Kastan; A T Look
Journal:  Nature       Date:  1996-08-08       Impact factor: 49.962

Review 5.  Chromosomal translocations in human cancer.

Authors:  T H Rabbitts
Journal:  Nature       Date:  1994-11-10       Impact factor: 49.962

6.  The WRPW motif of the hairy-related basic helix-loop-helix repressor proteins acts as a 4-amino-acid transcription repression and protein-protein interaction domain.

Authors:  A L Fisher; S Ohsako; M Caudy
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

7.  AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.

Authors:  T Okuda; J van Deursen; S W Hiebert; G Grosveld; J R Downing
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

8.  TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis.

Authors:  S A Shurtleff; A Buijs; F G Behm; J E Rubnitz; S C Raimondi; M L Hancock; G C Chan; C H Pui; G Grosveld; J R Downing
Journal:  Leukemia       Date:  1995-12       Impact factor: 11.528

9.  Groucho is required for Drosophila neurogenesis, segmentation, and sex determination and interacts directly with hairy-related bHLH proteins.

Authors:  Z Paroush; R L Finley; T Kidd; S M Wainwright; P W Ingham; R Brent; D Ish-Horowicz
Journal:  Cell       Date:  1994-12-02       Impact factor: 41.582

10.  E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements.

Authors:  G Bain; E C Maandag; D J Izon; D Amsen; A M Kruisbeek; B C Weintraub; I Krop; M S Schlissel; A J Feeney; M van Roon
Journal:  Cell       Date:  1994-12-02       Impact factor: 41.582

View more
  15 in total

1.  The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation.

Authors:  Masakazu Kogawa; Koji Hisatake; Gerald J Atkins; David M Findlay; Yuichiro Enoki; Tsuyoshi Sato; Peter C Gray; Yukiko Kanesaki-Yatsuka; Paul H Anderson; Seiki Wada; Naoki Kato; Aya Fukuda; Shigehiro Katayama; Masafumi Tsujimoto; Tetsuya Yoda; Tatsuo Suda; Yasushi Okazaki; Masahito Matsumoto
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

2.  Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression.

Authors:  Katharina H Ruebel; Alexey A Leontovich; Long Jin; Gail A Stilling; Heyu Zhang; Xiang Qian; Nobuki Nakamura; Bernd W Scheithauer; Kalman Kovacs; Ricardo V Lloyd
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

3.  Evolution of the Groucho/Tle gene family: gene organization and duplication events.

Authors:  Baubak Bajoghli
Journal:  Dev Genes Evol       Date:  2007-07-12       Impact factor: 0.900

Review 4.  Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia.

Authors:  Rajesh Somasundaram; Mahadesh A J Prasad; Jonas Ungerbäck; Mikael Sigvardsson
Journal:  Blood       Date:  2015-05-19       Impact factor: 22.113

5.  Transducin-like enhancer of split-6 (TLE6) is a substrate of protein kinase A activity during mouse oocyte maturation.

Authors:  Francesca E Duncan; Elizabeth Padilla-Banks; Miranda L Bernhardt; Teri S Ord; Wendy N Jefferson; Stuart B Moss; Carmen J Williams
Journal:  Biol Reprod       Date:  2014-03-20       Impact factor: 4.285

6.  Antagonistic effects of Grg6 and Groucho/TLE on the transcription repression activity of brain factor 1/FoxG1 and cortical neuron differentiation.

Authors:  Nathalie Marçal; Harshila Patel; Zhifeng Dong; Stephanie Belanger-Jasmin; Brad Hoffman; Cheryl D Helgason; Jinjun Dang; Stefano Stifani
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

7.  WD40 domain divergence is important for functional differences between the fission yeast Tup11 and Tup12 co-repressor proteins.

Authors:  Monica E Ferreira; Kurt D Berndt; Johan Nilsson; Anthony P H Wright
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

8.  Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation.

Authors:  Gareth Brady; Hannah J Whiteman; Lindsay C Spender; Paul J Farrell
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

9.  Effects of TGFbeta1 on gene expression in the HP75 human pituitary tumor cell line identified by gene expression profiling.

Authors:  Katharina H Ruebel; Alexey A Leontovich; Yoshinori Tanizaki; Long Jin; Gail A Stilling; Shuya Zhang; Kendra Coonse; Bernd W Scheithauer; Matilde Lombardero; Kalman Kovacs; Ricardo V Lloyd
Journal:  Endocrine       Date:  2008-04-10       Impact factor: 3.633

10.  In vitro sensitivity to dasatinib in lymphoblasts from a patient with t(17;19)(q22;p13) gene rearrangement pre-B acute lymphoblastic leukemia.

Authors:  Jason M Glover; Marc Loriaux; Jeffrey W Tyner; Brian J Druker; Bill H Chang
Journal:  Pediatr Blood Cancer       Date:  2011-10-28       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.